4//SEC Filing
KURIYEL RALF 4
Accession 0000950170-24-030331
CIK 0000730272other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 8:24 PM ET
Size
8.4 KB
Accession
0000950170-24-030331
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
KURIYEL RALF
Senior VP, R&D
Transactions
- Exercise/Conversion
Common Stock
2024-03-11$86.10/sh+1,271$109,433→ 27,777 total - Sale
Common Stock
2024-03-11$193.73/sh−3,517$681,348→ 24,260 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-11+1,271→ 0 totalExercise: $86.10Exp: 2030-02-27→ Common Stock (1,271 underlying)
Footnotes (2)
- [F1]$193.73 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.64 to $194.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]This option is fully vested and exercisable.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeother
Related Parties
1- filerCIK 0001733143
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 8:24 PM ET
- Size
- 8.4 KB